Rubinstein, G., Izar, B., McDonnell, D. E., Fernandez Valledor, A., Fried, J. A., Clerkin, K., Lin, E. F., Lotan, D., Latif, F., Sayer, G., Uriel, N., & Raikhelkar, J. K. (2024). Recurrent melanoma 25 years after initial diagnosis, presenting as metastatic disease early after heart transplantation. Cardio-Oncology, 10(1). https://doi.org/10.1186/s40959-024-00273-7

Deffner, M., Schneider-Hohendorf, T., Schulte-Mecklenbeck, A., Falk, S., Lu, I.-N., Ostkamp, P., Müller-Miny, L., Schumann, E. M., Goelz, S., Cahir-McFarland, E., Thakur, K. T., De Jager, P. L., Klotz, L., Meyer zu Hörste, G., Gross, C. C., Wiendl, H., Grauer, O. M., & Schwab, N. (2024). Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy. Cell Reports Medicine, 5(7), 101622. https://doi.org/10.1016/j.xcrm.2024.101622

Chou, S., Alain, S., Cervera, C., Chemaly, R. F., Kotton, C. N., Lundgren, J., Papanicolaou, G. A., Pereira, M. R., Wu, J. J., Murray, R. A., Buss, N. E., & Fournier, M. (2023). Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. The Journal of Infectious Diseases, 229(2), 413–421. https://doi.org/10.1093/infdis/jiad293

Tong, C., Moayedi, Y., & Lumpkin, E. A. (2024). Merkel cells and keratinocytes in oral mucosa are activated by mechanical stimulation. Physiological Reports, 12(2). Portico. https://doi.org/10.14814/phy2.15826

O’Neil, D. S., Martei, Y. M., Crew, K. D., Castillo, B. S., Costa, P., Lim, T., Michel, A., Rubin, E., Goel, N., Hurley, J., Lopes, G., & Antoni, M. H. (2023). Time to Cancer Treatment and Chemotherapy Relative Dose Intensity for Patients With Breast Cancer Living With HIV. JAMA Network Open, 6(12), e2346223. https://doi.org/10.1001/jamanetworkopen.2023.46223

Holtan, S. G., Martens, M. J., Al Malki, M. M., Efebera, Y., Kitko, C. L., Reshef, R., Rezvani, A. R., Shaffer, B. C., Solh, M. M., Yao, J. M., Runaas, L., Elmariah, H., Larkin, K. T., El Jurdi, N. H., Gooptu, M., Loren, A. W., Hall, A. C., Alousi, A., Jamy, O., … Bolanos-Meade, J. (2023). Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation. Blood, 142(Supplement 1), 897–897. https://doi.org/10.1182/blood-2023-187859

Orlando, E. H., Gould, P., Cuzzo, B., Ford, M., Chen, Y., Sanjurjo, A., May, B., Tsapepas, D., Leeman-Neill, R. J., Bhagat, G., Dube, G., Morris, H., Arcasoy, S., Latif, F., Martinez, M., Pereira, M., Lipsky, A. H., Sawas, A., Reshef, R., … Amengual, J. E. (2023). The Effect of Preemptive Rituximab Treatment in Patients with EBV Viremia after Solid Organ Transplantation on the Development of Post-Transplant Lymphoproliferative Disorder. Blood, 142(Supplement 1), 990–990. https://doi.org/10.1182/blood-2023-177823

O’Neil, D. S., Ayeni, O. A., Farrow, H. A., Chen, W. C., Demetriou, G., Buccimazza, I., Čačala, S., Stopforth, L. W., Joffe, M., Antoni, M. H., Lopes, G., Pumpalova, Y. S., Mapanga, W., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., & Cubasch, H. (2023). The Impact of HIV Infection on Neoadjuvant and Adjuvant Chemotherapy Relative Dose Intensity in South African Patients with Breast Cancer. The Oncologist, 28(10), e921–e929. https://doi.org/10.1093/oncolo/oyad056

Williams, M. J., Amezcua, L., Chinea, A., Cohan, S., Okai, A., Okuda, D. T., Vargas, W., Belviso, N., Božin, I., Jiang, X., Lewin, J. B., Lyons, J., Shen, C., England, S. M., & Grimes, N. (2023). Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM. Neurology and Therapy, 12(5), 1669–1682. https://doi.org/10.1007/s40120-023-00517-1

Amezcua, L., Mao-Draayer, Y., Vargas, W. S., Farber, R., Schaefer, S., Branco, F., England, S. M., Belviso, N., Lewin, J. B., Mendoza, J. P., & Shankar, S. L. (2023). Efficacy of Dimethyl Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Analysis of the DEFINE, CONFIRM, and ENDORSE Studies. Neurology and Therapy, 12(3), 883–897. https://doi.org/10.1007/s40120-023-00475-8

Kinoshita, H., Mandava, M., Jensen-Wachspress, M., Lang, H., Joy, E., Tanna, J., McCann, C. D., O’Brien, S., Burnett, S., Shibli, A., Hoq, F., Bhatia, M., Hanley, P. J., Dávila Saldaña, B., Mahadeo, K. M., Bollard, C. M., Keller, M. D., & Abraham, A. (2023). Outcomes following posttransplant virus-specific T-cell therapy in patients with sickle cell disease. Blood Advances, 7(10), 2105–2116. https://doi.org/10.1182/bloodadvances.2022008219

Storaasli, S., Nakagawa, S., Singer, J. P., Fedoronko, D. A., Zhang, Y., Tsapepas, D., Rincon, M. E., Scheffert, J., Benvenuto, L., & Arcasoy, S. M. (2022). Quality of Life Outcomes and Associated Symptoms Reported by Lung Transplant Recipients Amidst COVID-19 Pandemic: Applying a Novel Assessment Tool. Transplantation Proceedings, 54(10), 2680–2687. https://doi.org/10.1016/j.transproceed.2022.07.001

Orlando, E., Ford, M., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). The Effect of Rituximab Treatment and Reducing Immunosuppression on the Development of Post-Transplant Lymphoproliferative Disorder in EBV-Positive Patients after Solid Organ Transplantation. Blood, 140(Supplement 1), 12085–12086. https://doi.org/10.1182/blood-2022-158050

Ford, M., Orlando, E., Jin, Z., Lipsky, A. H., Sawas, A., Pro, B., & Amengual, J. E. (2022). Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder. Blood, 140(Supplement 1), 3777–3778. https://doi.org/10.1182/blood-2022-160147

Briasoulis, A., Doulamis, I., & Kampaktsis, P. (2022). Characteristics, predictors and outcomes of early mTOR inhibitor use after heart transplantation: insights from the UNOS database. European Heart Journal, 43(Supplement_2). https://doi.org/10.1093/eurheartj/ehac544.1019

Kampaktsis, P. N., Doulamis, I. P., Asleh, R., Makri, E., Kalamaras, I., Papastergiopoulos, C., Emfietzoglou, M., Drosou, A., Van den Eynde, J., Alnsasra, H., Duque, E. R., & Briasoulis, A. (2022). Characteristics, Predictors, and Outcomes of Early mTOR Inhibitor Use After Heart Transplantation: Insights From the UNOS Database. Journal of the American Heart Association, 11(17). https://doi.org/10.1161/jaha.122.025507

Wu, X., Sosunov, A. A., Lado, W., Teoh, J. J., Ham, A., Li, H., Al-Dalahmah, O., Gill, B. J. A., Arancio, O., Schevon, C. A., Frankel, W. N., McKhann, G. M., Sulzer, D., Goldman, J. E., & Tang, G. (2022). Synaptic hyperexcitability of cytomegalic pyramidal neurons contributes to epileptogenesis in tuberous sclerosis complex. Cell Reports, 40(3), 111085. https://doi.org/10.1016/j.celrep.2022.111085

Briasoulis, A., Doulamis, I., Duque, E. R., Alvarez, P., & Kampaltsis, P. (2022). Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database. The Journal of Heart and Lung Transplantation, 41(4), S455. https://doi.org/10.1016/j.healun.2022.01.1149